Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$22.15M
308.05K shares
KUMAR NEIL plans to sell 308.05K shares of BRIDGEBIO PHARMA, INC. valued at approximately $22.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Conversion Management Incentive Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2026 | Conversion Management Incentive Units N/A | 120K | — |
| Total | 120K | ||
Completed
Units to sell
20K
Market value
$1.38M
Units to sell
20K
Market value
$1.38M
Units to sell
20K
Market value
$1.37M
Units to sell
20K
Market value
$1.37M
Units to sell
28.05K
Market value
$2.00M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Units to sell
20K
Market value
$1.44M
Planned — Approximate Date
Units to sell
120K
Market value
$8.90M
Units
308.05K
Value
$22.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/13/2026 | 20K | $1.38M | — | Completed |
3/13/2026 | 20K | $1.38M | — | Completed |
3/12/2026 | 20K | $1.37M | — | Completed |
3/12/2026 | 20K | $1.37M | — | Completed |
2/19/2026 | 28.05K | $2.00M | — | Completed |
2/11/2026 | 20K | $1.44M | — | Completed |
2/11/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
2/10/2026 | 20K | $1.44M | — | Completed |
| Planned — Approximate Date | ||||
4/9/2026 | 120K | $8.90M | NASDAQ | Planned |
| Total | 308.05K | $22.15M | ||